What is Collegium Pharmaceutical, Inc.'s jornay PM — cost?

Collegium Pharmaceutical, Inc. (COLL) reported jornay PM — cost of $635M in Q1 2026.

How has Collegium Pharmaceutical, Inc.'s jornay PM — cost changed year-over-year?

Collegium Pharmaceutical, Inc.'s jornay PM — cost decreased by 0.0% year-over-year, from $635M to $635M.

What does jornay PM — cost mean?

This metric reflects the direct costs associated with the production, manufacturing, and supply chain logistics of a specific pharmaceutical product. Monitoring this helps evaluate the gross margin efficiency and cost-to-serve profile of the product line.

Collegium Pharmaceutical, Inc. COLL Jornay PM — Cost

Other product segments

Belbuca

$360M0.0%

Symproic

$70M0.0%

Symproic and other

$70M0.0%

Similar metrics at other companies

KURAProduct — Cost Of Product Sales

$14.25K—

CSCOAPJC — Total cost of sales

$752M+12.7%

AVNSPM&R — Cost of goods sold

-$21.7M-4.8%

CRCTProducts Member — Cost of Revenue

$70.59M-12.4%

QDELJPAC — Cost of sales, excluding amortization of intangibles

$41.5M+9.5%

OIIProduct — Cost of services and products

$115.3M-3.1%

Other financials

Income statement

See full

Revenue$193.5M+8.9%

Gross profit$117.2M+20.5%

Operating income$30.9M+42.5%

Net income$14.5M+500%

EPS (diluted)$0.40+471%

Balance sheet

See full

Cash & equivalents$289.6M+147%

Total debt$5.2M-19.5%

Total equity$312.4M+33.3%

Total assets$1.7B+1.3%

Cash flow

See full

Operating cash flow$57.1M+3.1%

CapEx$270.0K-66.2%

Free cash flow$56.8M+4.1%

Valuation

See full

Market cap$1.15B+17.9%

Enterprise value$869.67M-0.3%

P/E15.4×-6.9×

P/S1.5×0.0×

Profitability

See full

Gross margin60.7%+3.0pp

Operating margin23.7%+2.3pp

Net margin9.4%+2.8pp

FCF margin41.4%+10.4pp

Returns & leverage

See full

Return on equity27.4%+8.2pp

Debt / equity0×0.0×

Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s jornay pm — cost.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s jornay PM — cost?: Collegium Pharmaceutical, Inc. (COLL) reported jornay PM — cost of $635M in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s jornay PM — cost changed year-over-year?: Collegium Pharmaceutical, Inc.'s jornay PM — cost decreased by 0.0% year-over-year, from $635M to $635M.
What does jornay PM — cost mean?: This metric reflects the direct costs associated with the production, manufacturing, and supply chain logistics of a specific pharmaceutical product. Monitoring this helps evaluate the gross margin efficiency and cost-to-serve profile of the product line.